Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-19 ECKERT ROBERT Director Grant or award +665 26,251
2025-05-23 ECKERT ROBERT Director Grant or award +809 25,027
2024-05-31 ECKERT ROBERT Director Grant or award +719 23,715
2023-05-19 ECKERT ROBERT Director Grant or award +939 22,465
2022-08-18 ECKERT ROBERT Director Sale −6,600 $249.00 $1.6M 21,184
2022-08-10 ECKERT ROBERT Director Option exercise +20,000 $85.59 $1.7M 34,575
2022-08-10 ECKERT ROBERT Director Shares withheld for taxes −6,791 $252.09 $1.7M 27,784
2022-08-10 ECKERT ROBERT Director Option exercise · Nqso (Right to Buy) −20,000 0
2022-05-17 ECKERT ROBERT Director Grant or award +855 14,461
2021-05-18 ECKERT ROBERT Director Grant or award +837 13,199

Page 1 of 1 · 10 trades